세계의 보조생식기술 시장 : 유형별, 진단별, 최종 사용자별 예측(2025-2030년)

The Assisted Reproductive Technology Market was valued at USD 25.12 billion in 2023, expected to reach USD 29.52 billion in 2024, and is projected to grow at a CAGR of 17.57%, to USD 78.04 billion by 2030.

Assisted Reproductive Technology (ART) encompasses medical procedures used to address infertility, including in vitro fertilization (IVF), artificial insemination, and cryopreservation. The necessity of ART stems from rising infertility rates due to lifestyle changes, aging populations, and increased incidences of medical conditions like polycystic ovary syndrome. It is applied in clinics and hospitals to help individuals and couples conceive, catering primarily to families seeking to overcome various fertility challenges. The end-use sectors are primarily healthcare facilities and fertility centers. The market for ART is driven by advancements in medical technologies, growing awareness about fertility treatments, and increasing acceptance of ART procedures across various demographics. Additionally, governmental support and favorable regulations in many regions are contributing to market expansion. Key opportunities arise from technological innovations, such as AI and machine learning algorithms that enhance procedure success rates, and expanding services in emerging markets where fertility treatment demand is rising. However, challenges include high costs, ethical concerns, and limited access in certain regions, alongside a lack of skilled professionals in some areas. Additionally, societal and cultural stigmas can hinder adoption rates. Future innovations could focus on improving technique success rates, reducing costs, and personalizing treatments through genetic mapping and enhanced patient experience. Critical areas ripe for research and development include non-invasive diagnostic tools, improved embryo selection methods, and hormone therapy alternatives. For business growth, expanding services to emerging markets and investing in telehealth for initial consultations could prove beneficial. The ART market is dynamic, with significant growth potential, driven by technological advancements and the increasing prevalence of infertility. However, navigating ethical, cultural, and cost-related challenges will be crucial for sustained success.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Assisted Reproductive Technology Market

The Assisted Reproductive Technology Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

• Market Drivers
  • Growing number of infertility cases due to stress, pollution, and obesity
  • Rising healthcare expenditure across emerging nations
  • Increasing prevalence of ovarian & endometrial cancer and PCOS issues
• Market Restraints
  • High cost required for the procedure and lower success rate
• Market Opportunities
  • Initiatives from government and public organizations to increase awareness
  • Technological advancements to reduce the treatment complications
• Market Challenges
  • Dearth of advanced infrastructure in developing economies

Porter's Five Forces: A Strategic Tool for Navigating the Assisted Reproductive Technology Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Assisted Reproductive Technology Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Assisted Reproductive Technology Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Assisted Reproductive Technology Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Assisted Reproductive Technology Market

A detailed market share analysis in the Assisted Reproductive Technology Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Assisted Reproductive Technology Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Assisted Reproductive Technology Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Assisted Reproductive Technology Market

A strategic analysis of the Assisted Reproductive Technology Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Assisted Reproductive Technology Market, highlighting leading vendors and their innovative profiles. These include Carl Zeiss AG, CCB Kitazato, LLC, CooperSurgical, Inc. Cooper Companies Inc., Cryolab Ltd., Esco Micro Pte. Ltd.Esco Lifesciences Group, Ferring B.V., FUJIFILM Irvine Scientific, Inc., Genea Limited, INVO Bioscience, Merck & Co., Inc., Nidacon International AB, Planer PLC by Hamilton Thorne, Inc., Rocket Medical plc by Roko AB, Thermo Fisher Scientific company, and Vitrolife AB.

Market Segmentation & Coverage

This research report categorizes the Assisted Reproductive Technology Market to forecast the revenues and analyze trends in each of the following sub-markets:

• Based on Type, market is studied across Artificial Insemination, Donor Conception, Gamete Intrafallopian Transfer, In Vitro Fertilization, Ovulation Induction, and Surrogacy.
• Based on Diagnosis, market is studied across Genetic Testing, Hormone Testing, Hysterosalpingography, Imaging Testing, Ovarian Reserve Testing, and Ovulation Testing.
• Based on End User, market is studied across Clinics, Gynecology Centers, Hospitals, and In Vitro Fertilisation Centers.
• Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Segmentation & Coverage
• 1.3. Years Considered for the Study
• 1.4. Currency & Pricing
• 1.5. Language
• 1.6. Stakeholders

2. Research Methodology

• 2.1. Define: Research Objective
• 2.2. Determine: Research Design
• 2.3. Prepare: Research Instrument
• 2.4. Collect: Data Source
• 2.5. Analyze: Data Interpretation
• 2.6. Formulate: Data Verification
• 2.7. Publish: Research Report
• 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

• 5.1. Market Dynamics
  • 5.1.1. Drivers
    • 5.1.1.1. Growing number of infertility cases due to stress, pollution, and obesity
    • 5.1.1.2. Rising healthcare expenditure across emerging nations
    • 5.1.1.3. Increasing prevalence of ovarian & endometrial cancer and PCOS issues
  • 5.1.2. Restraints
    • 5.1.2.1. High cost required for the procedure and lower success rate
  • 5.1.3. Opportunities
    • 5.1.3.1. Initiatives from government and public organizations to increase awareness
    • 5.1.3.2. Technological advancements to reduce the treatment complications
  • 5.1.4. Challenges
    • 5.1.4.1. Dearth of advanced infrastructure in developing economies
• 5.2. Market Segmentation Analysis
• 5.3. Porter's Five Forces Analysis
  • 5.3.1. Threat of New Entrants
  • 5.3.2. Threat of Substitutes
  • 5.3.3. Bargaining Power of Customers
  • 5.3.4. Bargaining Power of Suppliers
  • 5.3.5. Industry Rivalry
• 5.4. PESTLE Analysis
  • 5.4.1. Political
  • 5.4.2. Economic
  • 5.4.3. Social
  • 5.4.4. Technological
  • 5.4.5. Legal
  • 5.4.6. Environmental

6. Assisted Reproductive Technology Market, by Type

• 6.1. Introduction
• 6.2. Artificial Insemination
• 6.3. Donor Conception
• 6.4. Gamete Intrafallopian Transfer
• 6.5. In Vitro Fertilization
• 6.6. Ovulation Induction
• 6.7. Surrogacy

7. Assisted Reproductive Technology Market, by Diagnosis

• 7.1. Introduction
• 7.2. Genetic Testing
• 7.3. Hormone Testing
• 7.4. Hysterosalpingography
• 7.5. Imaging Testing
• 7.6. Ovarian Reserve Testing
• 7.7. Ovulation Testing

8. Assisted Reproductive Technology Market, by End User

• 8.1. Introduction
• 8.2. Clinics
• 8.3. Gynecology Centers
• 8.4. Hospitals
• 8.5. In Vitro Fertilisation Centers

9. Americas Assisted Reproductive Technology Market

• 9.1. Introduction
• 9.2. Argentina
• 9.3. Brazil
• 9.4. Canada
• 9.5. Mexico
• 9.6. United States

10. Asia-Pacific Assisted Reproductive Technology Market

• 10.1. Introduction
• 10.2. Australia
• 10.3. China
• 10.4. India
• 10.5. Indonesia
• 10.6. Japan
• 10.7. Malaysia
• 10.8. Philippines
• 10.9. Singapore
• 10.10. South Korea
• 10.11. Taiwan
• 10.12. Thailand
• 10.13. Vietnam

11. Europe, Middle East & Africa Assisted Reproductive Technology Market

• 11.1. Introduction
• 11.2. Denmark
• 11.3. Egypt
• 11.4. Finland
• 11.5. France
• 11.6. Germany
• 11.7. Israel
• 11.8. Italy
• 11.9. Netherlands
• 11.10. Nigeria
• 11.11. Norway
• 11.12. Poland
• 11.13. Qatar
• 11.14. Russia
• 11.15. Saudi Arabia
• 11.16. South Africa
• 11.17. Spain
• 11.18. Sweden
• 11.19. Switzerland
• 11.20. Turkey
• 11.21. United Arab Emirates
• 11.22. United Kingdom

12. Competitive Landscape

• 12.1. Market Share Analysis, 2023
• 12.2. FPNV Positioning Matrix, 2023
• 12.3. Competitive Scenario Analysis
• 12.4. Strategy Analysis & Recommendation

Companies Mentioned

• 1. Carl Zeiss AG
• 2. CCB Kitazato, LLC
• 3. CooperSurgical, Inc. Cooper Companies Inc.
• 4. Cryolab Ltd.
• 5. Esco Micro Pte. Ltd.Esco Lifesciences Group
• 6. Ferring B.V.
• 7. FUJIFILM Irvine Scientific, Inc.
• 8. Genea Limited
• 9. INVO Bioscience
• 10. Merck & Co., Inc.
• 11. Nidacon International AB
• 12. Planer PLC by Hamilton Thorne, Inc.
• 13. Rocket Medical plc by Roko AB
• 14. Thermo Fisher Scientific company
• 15. Vitrolife AB